Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

p53 Is a Master Regulator of Proteostasis in SMARCB1-Deficient Malignant Rhabdoid Tumors
Alessandro Carugo, Rosalba Minelli, Luigi Sapio, et al.
Cancer Cell (2019) Vol. 35, Iss. 2, pp. 204-220.e9
Open Access | Times Cited: 77

Showing 1-25 of 77 citing articles:

The SWI/SNF complex in cancer — biology, biomarkers and therapy
Priya Mittal, Charles W.M. Roberts
Nature Reviews Clinical Oncology (2020) Vol. 17, Iss. 7, pp. 435-448
Open Access | Times Cited: 472
Exploiting vulnerabilities of SWI/SNF chromatin remodelling complexes for cancer therapy
Marek Wanior, Andreas Krämer, Stefan Knapp, et al.
Oncogene (2021) Vol. 40, Iss. 21, pp. 3637-3654
Open Access | Times Cited: 110
Comprehensive Molecular Characterization Identifies Distinct Genomic and Immune Hallmarks of Renal Medullary Carcinoma
Pavlos Msaouel, Gabriel G. Malouf, Xiaoping Su, et al.
Cancer Cell (2020) Vol. 37, Iss. 5, pp. 720-734.e13
Open Access | Times Cited: 99
MHC class I dysfunction of glioma stem cells escapes from CTL-mediated immune response via activation of Wnt/β-catenin signaling pathway
Wei Yang, Yanyan Li, Ruoling Gao, et al.
Oncogene (2019) Vol. 39, Iss. 5, pp. 1098-1111
Closed Access | Times Cited: 90
The Role of ARID1A in Tumors: Tumor Initiation or Tumor Suppression?
Shouying Xu, Chao Tang
Frontiers in Oncology (2021) Vol. 11
Open Access | Times Cited: 67
SMARCB1-Deficient Cancers: Novel Molecular Insights and Therapeutic Vulnerabilities
Garrett W. Cooper, Andrew L. Hong
Cancers (2022) Vol. 14, Iss. 15, pp. 3645-3645
Open Access | Times Cited: 43
The Impact of Oxidative Stress and AKT Pathway on Cancer Cell Functions and Its Application to Natural Products
Jun‐Ping Shiau, Ya-Ting Chuang, Jen‐Yang Tang, et al.
Antioxidants (2022) Vol. 11, Iss. 9, pp. 1845-1845
Open Access | Times Cited: 42
The IL6/JAK/STAT3 signaling axis is a therapeutic vulnerability in SMARCB1-deficient bladder cancer
Chandra Sekhar Amara, Karthik Reddy Kami Reddy, Yuntao Yang, et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 13
Hallmark discoveries in the biology of non-Wilms tumour childhood kidney cancers
Daniela Perotti, Maureen J. O’Sullivan, Amy L. Walz, et al.
Nature Reviews Urology (2025)
Closed Access | Times Cited: 1
SMARCB1-deficient poorly differentiated testicular carcinoma: a case report
Zhiying Wang, Zhixian Zhong, Yi Zhong, et al.
Frontiers in Oncology (2025) Vol. 15
Open Access | Times Cited: 1
MYC and the unfolded protein response in cancer: synthetic lethal partners in crime?
Tingting Zhang, Ningning Li, Chaoyang Sun, et al.
EMBO Molecular Medicine (2020) Vol. 12, Iss. 5
Open Access | Times Cited: 64
Proteotoxic Stress and Cell Death in Cancer Cells
Claudio Brancolini, Luca Iuliano
Cancers (2020) Vol. 12, Iss. 9, pp. 2385-2385
Open Access | Times Cited: 55
Clinico-pathological implications of the 2022 WHO Renal Cell Carcinoma classification
Mimma Rizzo, Anna Caliò, Matteo Brunelli, et al.
Cancer Treatment Reviews (2023) Vol. 116, pp. 102558-102558
Closed Access | Times Cited: 21
Recent progress and novel approaches to treating atypical teratoid rhabdoid tumor
Elizabeth Alva, Jeffrey Rubens, Susan Chi, et al.
Neoplasia (2023) Vol. 37, pp. 100880-100880
Open Access | Times Cited: 19
SMARCB1 regulates a TFCP2L1-MYC transcriptional switch promoting renal medullary carcinoma transformation and ferroptosis resistance
Bujamin Vokshi, Guillaume Davidson, Nassim Tawanaie Pour Sedehi, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 17
Exploiting the Therapeutic Interaction of WNT Pathway Activation and Asparaginase for Colorectal Cancer Therapy
Laura Hinze, Roxane Labrosse, James Degar, et al.
Cancer Discovery (2020) Vol. 10, Iss. 11, pp. 1690-1705
Open Access | Times Cited: 46
Remodeling the cancer epigenome: mutations in the SWI/SNF complex offer new therapeutic opportunities
Krystal A. Orlando, Vinh Nguyen, Jesse R. Raab, et al.
Expert Review of Anticancer Therapy (2019) Vol. 19, Iss. 5, pp. 375-391
Open Access | Times Cited: 45
Organoid-based drug screening reveals neddylation as therapeutic target for malignant rhabdoid tumors
Camilla Calandrini, Sander R. van Hooff, Irene Paassen, et al.
Cell Reports (2021) Vol. 36, Iss. 8, pp. 109568-109568
Open Access | Times Cited: 40
PTEN deficiency leads to proteasome addiction: a novel vulnerability in glioblastoma
Jorge A. Benítez, Darren Finlay, Anthony S. Castanza, et al.
Neuro-Oncology (2021)
Open Access | Times Cited: 35
Current and Emerging Therapeutic Approaches for Extracranial Malignant Rhabdoid Tumors
Karolina Nemes, Pascal D. Johann, Stefanie Tüchert, et al.
Cancer Management and Research (2022) Vol. Volume 14, pp. 479-498
Open Access | Times Cited: 24
(mis)-Targeting of SWI/SNF complex(es) in cancer
Divya Reddy, Saikat Bhattacharya, Jerry L. Workman
Cancer and Metastasis Reviews (2023) Vol. 42, Iss. 2, pp. 455-470
Open Access | Times Cited: 16
Antineoplastics for treating Alzheimer's disease and dementia: Evidence from preclinical and observational studies
Viswanath Das, John H. Miller, Alladi Charanraj Goud, et al.
Medicinal Research Reviews (2024) Vol. 44, Iss. 5, pp. 2078-2111
Open Access | Times Cited: 5
SMARCB1 loss interacts with neuronal differentiation state to block maturation and impact cell stability
Alison D. Parisian, Tomoyuki Koga, Shunichiro Miki, et al.
Genes & Development (2020) Vol. 34, Iss. 19-20, pp. 1316-1329
Open Access | Times Cited: 36
Loss of ARID1A Promotes Epithelial–Mesenchymal Transition and Sensitizes Pancreatic Tumors to Proteotoxic Stress
Hideo Tomihara, Federica Carbone, Luigi Perelli, et al.
Cancer Research (2020) Vol. 81, Iss. 2, pp. 332-343
Open Access | Times Cited: 36
Progress Update in Pediatric Renal Tumors
Juhi Jain, Kathryn S. Sutton, Andrew L. Hong
Current Oncology Reports (2021) Vol. 23, Iss. 3
Closed Access | Times Cited: 28
Page 1 - Next Page

Scroll to top